Home / GLP-1 appeals / Mounjaro / Centene

Mounjaro denial · Centene

Centene denied your Mounjaro. Here is how to appeal it.

Many Centene and Ambetter Mounjaro denials are winnable, if your appeal answers the plan's own criteria and lands before the deadline. We draft it for free, grounded in your plan's actual coverage rules with every citation verified. You review, sign, and file it.

Check my Centene denial, free See the strategy

Free to draft. Every citation checked against your plan's policy before you file.

Your deadline

Often 60 days

For the internal appeal on Centene Medicaid and Ambetter plans, measured from the determination notice. Some states allow longer. Your notice controls, check it.

Most common reason

Off-label or step therapy

Mounjaro is approved for type 2 diabetes, so a weight-loss prescription, or a missing first-line trial, is a frequent denial trigger.

What wins

A documented appeal

Published figures show Centene reverses a large share of internal appeals. Most denials are never challenged, so filing well-documented matters.

Why Centene denies Mounjaro

Mounjaro (tirzepatide) is FDA-approved to improve blood sugar in adults with type 2 diabetes. It is not FDA-approved for weight loss; that indication belongs to Zepbound, the same molecule under a different brand. That distinction drives most Centene denials:

  • Prescribed off-label for weight loss. When the records do not show a type 2 diabetes diagnosis, the plan reads the request as off-label and denies it. The first question to settle is which indication your prescription is actually for.
  • Step therapy or fail-first. Many plans require a documented trial of metformin or another preferred agent before Mounjaro. If your records do not show the trial or a reason you cannot take it, the claim is denied.
  • Formulary tier or quantity limit. The plan may prefer a different GLP-1 or cap the quantity. A denial here is about formulary placement, not whether the drug is appropriate for you.
  • Medical necessity criteria not met. Centene applies InterQual or its own clinical policy, often without a fully individualized review, so a documentation gap on your diabetes history can read as a denial even when the diagnosis is clear in your chart.

How to win the appeal with Centene

The pattern that works against Centene is documentation: most denials are never appealed, and a large share that are get reversed. Anchor the appeal to the type 2 diabetes indication and make the criteria a clean match.

The move: establish the on-label use. If Mounjaro is for type 2 diabetes, lead with the diagnosis, the A1c and labs, and the step-therapy history, then request the specific criteria the plan applied and answer each one. Centene reverses a substantial share of internal appeals, and many denials are issued without individualized review.

  • Document the diabetes diagnosis. Include the type 2 diabetes diagnosis, A1c and glucose labs, and the treatment history, so the on-label indication is unambiguous.
  • Clear the step-therapy hurdle. Show the trial of metformin or other preferred agents, or document the contraindication or intolerance that justifies skipping it.
  • File within the window. The internal appeal on Centene Medicaid and Ambetter plans is commonly 60 days from the determination notice. Designate an authorized representative in writing if someone is appealing on your behalf, which Centene requires before it will process a third-party appeal.
  • Know the external step. On Ambetter marketplace plans there is no minimum dollar amount to qualify for an independent external review, and that decision is binding on the plan. On Medicaid, you also have the right to a state fair hearing after the internal appeal.

Sources include your Centene or Ambetter plan's published coverage policy and the Mounjaro prescribing information. We cite the specific policy that applies to your plan when we build your appeal.

The magic is visible

Your appeal, built from your plan's own rules. Every citation checked.

We draft from the sources below, then verify each one before you file. On our held-out testing: 0 invented citations, versus about 1 in 4 for raw AI.

  • Centene's coverage policyThe Centene or Ambetter clinical policy and criteria for GLP-1 agents that apply to your planVerified
  • FDA labelTirzepatide (Mounjaro) prescribing information, type 2 diabetes indication and dosingVerified
  • Your recordsYour type 2 diabetes diagnosis, A1c and labs, and prior diabetes therapies, cited back accuratelyVerified

Let's check your Centene denial, free.

Answer a few questions for an honest read on your odds, then your verified draft. No account, no cost.

Check my denial, free

Centene + Mounjaro: common questions

How long do I have to appeal?
On Centene Medicaid and Ambetter marketplace plans, the internal appeal is commonly 60 calendar days from the determination notice, though some states allow longer. Your denial notice states the deadline that applies to you, and that controls. File as early as you can.
I was prescribed Mounjaro for weight loss, can I still appeal?
You can, but it helps to understand the framing. Mounjaro is FDA-approved for type 2 diabetes, not weight loss. If you have type 2 diabetes, lead with that diagnosis. If the goal is weight management, Zepbound is the same molecule that is FDA-approved for it, and is often the stronger path. We will tell you honestly which fits your situation.
What if I have not tried metformin?
Step therapy can often be satisfied by documenting a contraindication, an intolerance, or a prior failure of the preferred agent. If none applies, the appeal is harder, and we will say so plainly.
Is this really free?
Yes. We draft your appeal for free and you file it. No fee, no contingency, nothing taken from coverage you win. AppealIt is not a law firm and does not provide legal or medical advice.

Other Mounjaro appeals: Molina · HCSC · Aetna · All Mounjaro denials